Recall
FDAHealthMay 18, 2026

Eugia US LLC — Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

⚠️ Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
May 18, 2026

US Nationwide.

What's affected?

Product
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Lot code
3LC26029A

Additional details

Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029

What should I do?

Recommended action

Class III recall. Voluntary: Firm initiated Quantity affected: 168,300 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.